Archives: Agenda
PANEL DISCUSSION Choosing Where to Run Clinical Trials in 2027 and Balancing Speed, Quality and Access
- Comparing timelines and setup across the UK EU and other key regions
- Understanding trade-offs between speed cost quality and patient access
- Deciding how to prioritise regions based on trial type and strategy
1 x Biopharma panel seat available
1 x Vendor panel seat available
Session reserved for event sponsor
Session reserved for
Chairperson’s Opening Remarks
Registration and Refreshments
NETWORKING DRINKS
STANDUP COMEDY Taking a light-hearted look at the realities of working in clinical trials and life sciences
Session reserved for event sponsor
ASK THE EXPERT SESSION Understanding The Key Criteria Investors Use When Selecting Biotech to Fund
- Identifying how clinical strategy and data quality impact investment decisions
- Translating investor expectations into practical changes in trial design and execution
- Applying these insights to improve funding strategy in a tougher market